Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI8852 in Hospitalized Influenza A
NCT03028909Phase 2Withdrawn
- Sponsor
- MedImmune
- Start
- Jul 2017
- Primary completion
- Jul 2019
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of MEDI8852 in Influenza A (IAV), sponsored by MedImmune. Planned start Jul 2017; status: withdrawn.
02
Drugs
MEDI8852
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT03028909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028909.